secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001193125-23-164486
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences stockholders elect four Class II directors, ratify auditor, approve ESPP amendment
--------------------------------------------------------------------------------

- Elected Clare Kahn, Adam Koppel, Adam Stone, Lynne Sullivan as Class II directors to 2026; votes ranged 13.6M–14.2M for, 76K–664K withheld.
- Ratified PricewaterhouseCoopers LLP as auditor for FY 2023 with 15.3M for, 4.9K against, 5.5K abstain.
- Approved amendment to 2021 ESPP increasing shares available for issuance; 13.6M for, 679K against, 4K abstain.
- All results from June 6, 2023 Annual Meeting; broker non-votes of ~1.1M on director election and ESPP amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/0001193125-23-164486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312523164486/d513689d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-164486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer